Newborn Screening Assays

GUANGZHOU FENGHUA BIOENGINEERING CO.,LTD

Guangzhou, Guangdong, China

FENGHUA has established strategic cooperation with multiple reputable universities, research institutes, and high-tech enterprises. We dedicated to meeting the clinical demands, by developing instruments and reagents with our intellectual properties. In the past 20 years, we have built up a team with strong R D abilities, integrated technical and customer-oriented marketing support; exceeding our competitors by the year-by-year excellent financial status and reliable social and business partners. In addition, we possess over 100 products (including reagents and instruments) that are CFDA-certified and CE-marked. Before being introduced to the market, our products are comprehensively validated to ensure that they meet the highest standards in clinical diagnostics. The product quality is extensively and continuously monitored after launching onto the market. We have acquired CE certificates, FSC certificates, ISO 9001:2008 and ISO 13485:2012 quality system certifications. FENGHUA offers best-in-class technologies for clinical analysis by immunoassay (such as LIA, TRFIA), HPLC and mass spectrometry, and is specialized in the diagnosis of prenatal screening, neonatal screening, reproductive health, diabetes, infectious diseases, etc. Our solutions have been used in hundreds of clinical laboratories to provide reliable and accurate results.